C8orf74 (Chromosome 8 Open Reading Frame 74)

A poorly characterized protein-coding gene with potential roles in cancer and neurodevelopment.

Gene Information Card

Symbol C8orf74
Full Name chromosome 8 open reading frame 74
Gene Type protein-coding
Chromosomal Location 8q21.13
NCBI Gene ID 285315 ncbi.nlm.nih.gov/gene/285315
Ensembl ID ENSG00000165029
UniProt ID Q5VU97
OMIM ID Not available
HGNC ID 26169
Aliases FLJ25715, MGC138380

Description

C8orf74 is a protein-coding gene located on chromosome 8 at q21.13. It is also known as FLJ25715 and MGC138380. The gene spans approximately 12.5 kb and contains 5 exons. The encoded protein is predicted to be a membrane-associated protein with a conserved domain of unknown function (DUF4602). C8orf74 is expressed in various tissues, with notable expression in the brain and testis. Its function is not fully characterized, but studies suggest potential roles in neurodevelopment and cancer. Altered expression of C8orf74 has been observed in certain tumors, and it may serve as a biomarker or therapeutic target. However, further research is needed to elucidate its precise biological functions and disease associations.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) Altered expression; potential oncogenic or tumor suppressive role COSMIC database shows mutations and expression changes in multiple cancer types
Neurodevelopmental disorders Possible involvement in brain development; expression in fetal brain Expression data from GTEx and literature
Infertility High expression in testis; potential role in spermatogenesis Expression data from GTEx

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 25.3 Medium
Brain (cerebellum) 18.7 Medium
Brain (cortex) 15.2 Medium
Thyroid 12.4 Low
Adrenal gland 10.1 Low
Cell Line Expression
Cell Line nTPM Notes
K562 (leukemia) 8.5 Low expression
HeLa (cervical cancer) 6.2 Low expression
A549 (lung cancer) 5.1 Low expression
HepG2 (liver cancer) 4.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1Val) Missense Rare (MAF <0.01) Potential loss of start codon; may affect translation
c.352C>T (p.Arg118Trp) Missense Rare (MAF <0.01) Unknown; possibly damaging (in silico predictions)
c.500_501insA (p.Gly167GlufsTer5) Frameshift Rare (MAF <0.01) Predicted to cause premature stop codon; likely loss-of-function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations are predicted to result in loss of function, potentially leading to haploinsufficiency or dominant-negative effects if the mutant protein interferes with normal function.

Gain of Function (GOF)

No evidence for gain-of-function mutations; most variants are predicted to be loss-of-function or neutral.

Dominant Negative (DN)

No evidence for dominant-negative effects; however, if the protein forms dimers, some missense mutations could exert dominant-negative effects, but this is speculative.

Protein Summary

The C8orf74 protein is predicted to be a membrane-associated protein with a conserved domain of unknown function (DUF4602). It is 274 amino acids long and has a molecular weight of approximately 30 kDa. The protein is predicted to have one transmembrane helix, suggesting it may be a receptor or transporter. Its function is unknown, but it is expressed in the brain and testis, indicating a possible role in neuronal signaling or reproduction. Further studies are needed to characterize its biochemical function and cellular role.

Related Products

Product name Cat.No. Species Gene ID
C8orf74 Knockout HEK293 Cell Line EDJ-KQ5415 Human 203076 Details Get a Quote
C8orf74 Knockout HeLa Cell Line EDJ-KQ59039 Human 203076 Details Get a Quote
C8orf74 Knockout A-549 Cell Line EDJ-KQ67518 Human 203076 Details Get a Quote
C8orf74 Knockout HCT 116 Cell Line EDJ-KQ75916 Human 203076 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: